Evotec SE (EVO) Short term Debt (2009 - 2026)

Evotec SE (EVO) reported Short term Debt of $103745.6 for Q1 2026, up 61.89% on a YoY basis from $64082.9 in Q1 2025, and down 14.89% sequentially from $121898.6 in Q4 2025.

Evotec SE (EVO) Short term Debt (2009 - 2026) Analysis & Trends

Evotec SE (EVO) has 9 years of Short term Debt data on file, last reported at $103745.6 in Q1 2026.

  • For the quarter ending Q1 2026, Short term Debt rose 61.89% year-over-year to $103745.6; the trailing twelve-month figure through Mar 2026 stood at $103745.6 (up 61.89% YoY), and the FY2025 full-year result was $121898.6, down 99.78% from the prior year.
  • Short term Debt eased to $103745.6 in Q1 2026, from $121898.6 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $54.3 million in Q4 2024 to a low of -$1860.9 in Q2 2022.
  • A 5-year average of $5.2 million and a median of $83914.3 in 2025 frame the typical range for Short term Debt.
  • Across the five-year window, Short term Debt slumped 99.85% in 2023 and jumped 504382.67% in 2024, its largest moves.
  • Tracing EVO's Short term Debt over 5 years: stood at $7.2 million in 2022, then tumbled by 99.85% to $10759.4 in 2023, then jumped by 504382.67% to $54.3 million in 2024, then plunged by 99.78% to $121898.6 in 2025, then dropped by 14.89% to $103745.6 in 2026.
  • Business Quant data shows EVO's Short term Debt at $103745.6 in Q1 2026, $121898.6 in Q4 2025, and $113249.9 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Evotec SE 351.60 Mn 351.08 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 103,745.63
Dec 31, 2025 121,898.64
Sep 30, 2025 113,249.87
Jun 30, 2025 120,963.48
Mar 31, 2025 64,082.90
Dec 31, 2024 54.28 Mn
Sep 30, 2024 58,795.38
Dec 31, 2023 10,759.40
Dec 31, 2022 7.23 Mn
Sep 30, 2022 38,822.59
Jun 30, 2022 -1,860.95
Mar 31, 2022 40,566.90
Dec 31, 2021 41.34 Mn
Sep 30, 2021 41,275.06
Dec 31, 2020 18.35 Mn
Sep 30, 2010 254.38
Jun 30, 2010 362.05
Mar 31, 2010 653.58
Dec 31, 2009 716.22
Jun 30, 2009 818,350.63